Cargando…
The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma
BACKGROUND: Sorafenib is the first molecular-targeted drug for the treatment of advanced hepatocellular carcinoma (HCC). However, its treatment efficiency decreases after a short period of time because of the development of drug resistance. This study investigates the role of key genes in regulating...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299949/ https://www.ncbi.nlm.nih.gov/pubmed/34307151 http://dx.doi.org/10.3389/fonc.2021.685694 |